Medicine and Dentistry
Patient
100%
Infection
61%
Therapeutic Procedure
57%
Anti-biotics
49%
Sepsis
46%
Indigenous
33%
Hospital
31%
Hepatitis B
29%
Randomized Controlled Trial
29%
Infectious Disease
27%
Hepatitis B Virus
25%
Staphylococcus Aureus
23%
Physician
23%
Mortality
22%
Combination Therapy
22%
Inpatient
20%
COVID-19
19%
Association
19%
Adult
18%
Cohort Analysis
18%
Antibiotic Therapy
18%
Methicillin Resistant Staphylococcus Aureus Infection
17%
Clinical Trial
17%
Diseases
16%
Analysis
16%
Cohort Effect
15%
Plasma
15%
Lactam
14%
Incidence
14%
Infusion
14%
Bacteremia
14%
Chronic Hepatitis B
14%
Genotype
14%
Diagnosis
14%
β-Lactam antibiotic
14%
Clinician
13%
Athletic Training
13%
Age
13%
Health
12%
Prosthetics
11%
Infectious Arthritis
11%
Bloodstream Infection
11%
Vancomycin
11%
Hepatitis C
11%
Pneumonia
10%
Cross Sectional Study
10%
Upper Respiratory Tract Infection
9%
Arginine
9%
Consultation
9%
Follow up
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
27%
Vancomycin
19%
Antibiotic Agent
18%
Infection
16%
Sepsis
15%
Staphylococcus Aureus
14%
Lactam
13%
Cohort Study
13%
Randomized Controlled Trial
12%
Bacteremia
10%
Mortality
10%
Methicillin Resistant Staphylococcus Aureus Infection
9%
Pharmacokinetics
8%
Diseases
8%
Staphylococcal Bacteremia
8%
Beta Lactam Antibiotic
7%
Pneumonia
6%
Cefazolin
6%
Methicillin-Resistant Staphylococcus Aureus
6%
Flucloxacillin
6%
Acute Kidney Failure
6%
Bronchitis
6%
Respiratory Tract Infection
6%
Antibiotic Therapy
6%
Penicillin Derivative
5%
Drug
5%
Clinical Trial
5%
Upper Respiratory Tract Infection
5%
Daptomycin
5%
Clindamycin
5%
Nursing and Health Professions
Patient
27%
Sepsis
17%
Analysis
10%
Beta Lactam Antibiotic
10%
Infection
10%
Infusion
9%
Indigenous
9%
Lactam
8%
Physician
8%
Antibiotic Agent
7%
Hepatitis B
7%
Hospital
7%
Time
6%
Respiratory Tract Infection
6%
Mortality
6%
General Practise Registrar
6%
Diagnosis
5%
Meta Analysis
5%
Diseases
5%
Follow up
5%
